Shouyi Li

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Tianjin Medical University

Mudanjiang Medical University

Shouyi Li is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, malignant neoplasms, and therapeutic resistance.

Publications per year

2023–2025

Publications

Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress

Chunhua She, Chao Wu, Weihua Guo et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel Pt@PCN-Cu-induced cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation

Pengyu Wang, Weihua Guo, Shuyue Liu et al. · Journal of Experimental & Clinical Cancer Research · 2025 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis

Xiaomeng Liu, Zhe Li, Xinru Xie et al. · Drug Resistance Updates · 2025 · 12 citations

Medicine, Immunology, Pharmacology +14

1–3 of 3